Kenji Tsushima Selected Research

antithrombin III-protease complex

12/2021

Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Tsushima Research Topics

Disease

19	Lung Injury 01/2022 - 03/2004
11	Idiopathic Pulmonary Fibrosis 01/2020 - 12/2014
9	Neoplasms (Cancer) 01/2022 - 01/2007
8	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 01/2010
7	Respiratory Insufficiency (Respiratory Failure) 07/2022 - 01/2010
7	COVID-19 07/2022 - 01/2021
6	Pneumonia (Pneumonitis) 07/2022 - 05/2014
6	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2007
6	Disease Progression 04/2018 - 01/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 01/2004
5	Acute Lung Injury 12/2012 - 01/2002
3	Bacterial Pneumonia 07/2022 - 05/2014
3	Hemorrhage 01/2020 - 03/2004
3	Pulmonary Hypertension 04/2019 - 11/2010
3	Dyspnea (Shortness of Breath) 04/2019 - 01/2013
3	Pathologic Constriction (Stenosis) 01/2016 - 01/2007
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2014 - 01/2002
3	Fistula 10/2009 - 07/2004
2	Fever (Fevers) 12/2021 - 01/2015
2	Obesity 12/2021 - 01/2006
2	Inflammation (Inflammations) 04/2018 - 10/2009
2	Disseminated Intravascular Coagulation 01/2015 - 12/2014
2	Seminoma 08/2013 - 01/2008
2	Hyperplasia 11/2011 - 01/2006
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2010 - 06/2009
2	Hypoxia (Hypoxemia) 01/2010 - 01/2010
2	Pulmonary Edema 07/2008 - 07/2004
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2007 - 10/2006
2	Thymoma (Thymic Carcinoma) 07/2007 - 06/2002
2	Sepsis (Septicemia) 04/2007 - 01/2007
2	Tracheal Stenosis 01/2007 - 09/2006
1	Infections 07/2022
1	Body Weight (Weight, Body) 01/2022
1	Collagen Diseases (Collagen Disease) 12/2021

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
7	Oxygen (Dioxygen)IBA 07/2022 - 03/2010
6	AcidsIBA 11/2010 - 03/2004
5	nintedanibIBA 01/2020 - 01/2018
5	Cisplatin (Platino)FDA LinkGeneric 08/2013 - 06/2002
5	CytokinesIBA 01/2012 - 03/2004
5	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2010 - 01/2002
4	Immunoglobulin G (IgG)IBA 05/2011 - 01/2006
3	Gemcitabine FDA Link 01/2022 - 01/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2013
3	ThrombomodulinIBA 01/2020 - 12/2014
3	pirfenidoneIBA 01/2019 - 01/2017
3	Secretory Proteinase Inhibitory ProteinsIBA 06/2014 - 12/2004
3	AlbuminsIBA 12/2012 - 03/2004
3	Hydrochloric Acid (Hydrogen Chloride)FDA Link 02/2010 - 03/2004
2	ProcalcitoninIBA 07/2022 - 07/2022
2	C-Reactive ProteinIBA 07/2022 - 07/2022
2	SteroidsIBA 07/2022 - 07/2022
2	favipiravirIBA 07/2022 - 12/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2018
2	Everolimus FDA Link 01/2018 - 01/2013
2	AntigensIBA 07/2013 - 12/2007
2	InterleukinsIBA 12/2012 - 03/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2012 - 07/2004
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 11/2011
2	Interleukin-13IBA 11/2011 - 01/2006
2	sivelestatIBA 09/2010 - 12/2004
2	LipopolysaccharidesIBA 04/2010 - 03/2010
2	Chemotactic FactorsIBA 02/2010 - 03/2004
2	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2010 - 06/2009
2	Oleic Acid (Oleate)IBA 10/2009 - 07/2008
2	Docetaxel (Taxotere)FDA Link 05/2009 - 05/2009
2	Carboplatin (JM8)FDA LinkGeneric 07/2007 - 12/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 06/2002
2	Vincristine (Oncovin)FDA LinkGeneric 07/2007 - 06/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2007 - 06/2002
2	EndotoxinsIBA 04/2007 - 07/2004
1	camostatIBA 07/2022
1	ciclesonide FDA Link 07/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	antithrombin III-protease complexIBA 12/2021
1	plasmin-plasmin inhibitor complexIBA 12/2021
1	Fibrinogen (Factor I)FDA Link 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021

Therapy/Procedure

16	Therapeutics 07/2022 - 01/2004
11	Drug Therapy (Chemotherapy) 09/2019 - 06/2002
6	Artificial Respiration (Mechanical Ventilation) 07/2022 - 01/2007
5	Hemoperfusion 01/2010 - 01/2002
4	Cannula 07/2022 - 01/2006
3	Extracorporeal Membrane Oxygenation 07/2022 - 05/2018
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 07/2022 - 02/2012
3	Noninvasive Ventilation 01/2021 - 01/2010
3	Radiotherapy 09/2017 - 05/2009
3	Radiofrequency Ablation 01/2015 - 04/2010
3	Vascular Access Devices (Arterial Line) 10/2009 - 07/2004
2	Respiratory Therapy (Therapy, Respiratory) 07/2022 - 07/2022
2	Length of Stay 01/2022 - 01/2008
2	Lung Transplantation 05/2018 - 09/2016
2	Catheters 04/2010 - 01/2007
2	Argon Plasma Coagulation 01/2007 - 09/2006
1	Patient Discharge 07/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Blood Component Removal (Apheresis) 12/2021